(2021) Certolizumab pegol/infliximab. Reactions Weekly, 1836 (1) 223 doi:10.1007/s40278-021-88042-1
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Certolizumab pegol/infliximab | ||
Journal | Reactions Weekly | ||
Year | 2021 (January) | Volume | 1836 |
Issue | 1 | ||
Publisher | Springer Science and Business Media LLC | ||
DOI | doi:10.1007/s40278-021-88042-1Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 13413713 | Long-form Identifier | mindat:1:5:13413713:3 |
GUID | 0 | ||
Full Reference | (2021) Certolizumab pegol/infliximab. Reactions Weekly, 1836 (1) 223 doi:10.1007/s40278-021-88042-1 | ||
Plain Text | (2021) Certolizumab pegol/infliximab. Reactions Weekly, 1836 (1) 223 doi:10.1007/s40278-021-88042-1 | ||
In | (2021, January) Reactions Weekly Vol. 1836 (1) Springer Science and Business Media LLC |
See Also
These are possibly similar items as determined by title/reference text matching only.
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |